BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2814294)

  • 21. Histological Evaluation of the Relationships Between Distal Interphalangeal Psoriatic Arthritis and Nail Psoriasis: Correlations With Anatomical Studies of the Normal Nail Unit and the Main Radiological Data Concerning Distal Interphalangeal Psoriatic Arthritis.
    Perrin C
    Am J Dermatopathol; 2020 Dec; 42(12):911-915. PubMed ID: 32889808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Test yourself: answer psoriatic onycho-pachydermo periostitis (POPP).
    Bethapudi S; Halstead J; Ash Z; McGonagle D; Grainger AJ
    Skeletal Radiol; 2014 Mar; 43(3):409-11; 373-4. PubMed ID: 23828622
    [No Abstract]   [Full Text] [Related]  

  • 23. Is the involvement of the distal interphalangeal joint in psoriatic patients related to nail psoriasis?
    Scarpa R; Manguso F; Oriente A; Peluso R; Atteno M; Oriente P
    Clin Rheumatol; 2004 Feb; 23(1):27-30. PubMed ID: 14749978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound nail imaging on patients with psoriasis and psoriatic arthritis compared with rheumatoid arthritis and control subjects.
    Sandobal C; Carbó E; Iribas J; Roverano S; Paira S
    J Clin Rheumatol; 2014 Jan; 20(1):21-4. PubMed ID: 24356473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carnitine: a therapeutic option for childhood psoriatic onycho-pachydermo-periostitis (POPP).
    Fietta P; Manganelli P
    Clin Rheumatol; 2007 Jan; 26(1):93-4. PubMed ID: 16738841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psoriatic onycho-pachydermo-periostitis].
    Miehle W
    Z Rheumatol; 2002 Oct; 61(5):597. PubMed ID: 12399888
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab.
    Nakayama C; Fujita Y; Watanabe M; Shimizu H
    J Dermatol; 2015 Oct; 42(10):996-8. PubMed ID: 26010891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nail and distal interphalangeal joint in psoriatic arthritis.
    Scarpa R; Soscia E; Peluso R; Atteno M; Manguso F; Del Puente A; Spanò A; Sirignano C; Oriente A; Di Minno MN; Iervolino S; Salvatore M
    J Rheumatol; 2006 Jul; 33(7):1315-9. PubMed ID: 16758507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psoriatic onycho-pachydermo-periostitis (POPP)].
    Schröder K; Goerdt S; Sieper J; Krasagakis K; Almond-Roesler B; Orfanos CE
    Hautarzt; 1997 Jul; 48(7):500-3. PubMed ID: 9333632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriatic onycho-pachydermo periostitis: treatment with methotrexate.
    Bauzá A; Redondo P; Aquerreta D
    Br J Dermatol; 2000 Oct; 143(4):901-2. PubMed ID: 11069487
    [No Abstract]   [Full Text] [Related]  

  • 31. Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort Study.
    Antony AS; Allard A; Rambojun A; Lovell CR; Shaddick G; Robinson G; Jadon DR; Holland R; Cavill C; Korendowych E; McHugh NJ; Tillett W
    J Rheumatol; 2019 Sep; 46(9):1097-1102. PubMed ID: 30824637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pachydermoperiostosis and psoriatic onychopathy: an unusual association.
    Fietta P; Manganelli P
    J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):73-6. PubMed ID: 12602977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Psoriasiform onychopachydermoperiostitis of the large toes: the OP3GO syndrome].
    Ziemer A; Heider M; Göring HD
    Hautarzt; 1998 Nov; 49(11):859-62. PubMed ID: 9879487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid response to clinical symptoms in early psoriatic onycho-pachydermo-periostitis treated with infliximab.
    Horie K; Fujita Y; Hoshina D; Abe R; Shimizu H
    Australas J Dermatol; 2018 Feb; 59(1):e78-e79. PubMed ID: 28660645
    [No Abstract]   [Full Text] [Related]  

  • 35. Psoriatic Nail Changes Are Associated With Clinical Outcomes in Psoriatic Arthritis.
    Sandre MK; Rohekar S; Guenther L
    J Cutan Med Surg; 2015; 19(4):367-76. PubMed ID: 25775610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential response of psoriatic onycho-pachydermo-periostitis to 2 anti-tumor necrosis factor-alpha agents.
    Kapusta MA; Dumont C
    J Rheumatol; 2008 Oct; 35(10):2077-80. PubMed ID: 18843767
    [No Abstract]   [Full Text] [Related]  

  • 37. Recalcitrant psoriatic onycho-pachydermo-periostitis successfully treated with guselkumab.
    Brunasso AMG; Sola S; Massone C
    Clin Exp Dermatol; 2021 Jun; 46(4):789-791. PubMed ID: 33619743
    [No Abstract]   [Full Text] [Related]  

  • 38. Childhood onset of psoriatic onycho-pachydermo-periostitis (POPP).
    Fietta P; Manganelli P
    J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):780-2. PubMed ID: 16268902
    [No Abstract]   [Full Text] [Related]  

  • 39. Nail psoriasis as a predictor of the development of psoriatic arthritis.
    Raposo I; Torres T
    Actas Dermosifiliogr; 2015; 106(6):452-7. PubMed ID: 26026773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Incidence of signs indicating psoriatic rheumatism in radiological involvement of fingers and toes. Apropos of 193 cases of psoriatic arthropathy].
    Fournié B; Granel J; Bonnet M; Dromer C; Pagès M; Billey T; Fournié A
    Rev Rhum Mal Osteoartic; 1992 Mar; 59(3):177-80. PubMed ID: 1609235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.